Scientists test new malaria booster doses in african children
NCT ID NCT07074665
Summary
This study is testing a booster dose of the R21 malaria vaccine in school-aged children in Burkina Faso. It will compare two different strengths of the booster shot to see which is safer and produces a better immune response. The children in the study have already received a full course of the same vaccine when they were younger.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unité de Recherche Clinique de Nanoro (URCN)
RECRUITINGNanoro, PO Box 11 BP 218 Ouaga CMS 11, Burkina Faso
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.